Managing complications
Patients with untreated or improperly managed BPH may develop specific complications, such as urinary retention or (rarely) renal insufficiency.1 Complications of BPH can also result in the need for surgery. Clinicians need to be aware of these complications, make proper evaluations and provide referrals when appropriate.
American Urological Association (AUA) Treatment Algorithm
This algorithm for the treatment and diagnosis of benign prostatic hyperplasia was developed by the AUA. It includes initial evaluation as well as recommended approaches to invasive and noninvasive therapy.
Explore a variety of useful tools and resources for your practice
Important Safety Information
FLOMAX is indicated to treat the signs and symptoms of benign prostatic hyperplasia (BPH). FLOMAX is not indicated to treat hypertension. As with other alpha-adrenergic blocking agents, there is a potential risk of syncope. Patients beginning treatment with FLOMAX should be cautioned to avoid driving or hazardous tasks for 12 hours after their first dose or increase in dose should syncope occur. The most common side effects are dizziness, abnormal ejaculation, and rhinitis.
Caution should be exercised with concomitant administration of warfarin and FLOMAX. In addition, FLOMAX should be used with caution in combination with cimetidine, particularly at doses higher than 0.4 mg. FLOMAX is contraindicated in patients known to be hypersensitive to tamsulosin HCl or any component of FLOMAX.
Before prescribing FLOMAX, please see the full Prescribing Information.
